Asplund Monika, Calling Susanna, Spirén Anna, Svedman Cecilia
Hudklinken - Skånes Universitetssjukhus Malmö, Sweden Capio Citykliniken - Centrum Malmö, Sweden.
Centrum för Primärvårdsforskning - Clinical Research Centre (CRC), Skånes Universitetssjukhus Malmö, Sweden Centrum för Primärvårdsforskning - Clinical Research Centre (CRC), Skånes Universitetssjukhus Malmö, Sweden.
Lakartidningen. 2015 Dec 15;112:DRFM.
Prurigo nodularis is a pruritic condition characterized by skin noduli. Different treatment options have been used with limited success. Pregabalin is a drug licensed for treatment of neuropathic pain in adults. As prurigo nodularis involves suffering for the patients and is difficult to treat, the aim of this case report is to report the effect of pregabalin treatment in seven patients with prurigo nodularis, treated in the dermatology clinic in Malmö, Sweden. Four patients experienced good effect of pregabalin, though two patients had a transient effect. Side effects of pregabalin have been reported. This case report indicates that pregabalin is a treatment option for therapy-resistant prurigo nodularis; even though one must be aware of that the effect may not be permanent and that there are side effects. The aim must be to use the drug for a limited time, taking the patient to a remission state, where the vicious itch-scratch cycle can be inhibited.
结节性痒疹是一种以皮肤结节为特征的瘙痒性疾病。已采用多种不同的治疗方法,但效果有限。普瑞巴林是一种已获许可用于治疗成人神经性疼痛的药物。由于结节性痒疹给患者带来痛苦且难以治疗,本病例报告的目的是报告普瑞巴林治疗瑞典马尔默皮肤科诊所7例结节性痒疹患者的效果。4例患者对普瑞巴林有良好效果,尽管2例患者有短暂效果。普瑞巴林的副作用已有报道。本病例报告表明,普瑞巴林是治疗难治性结节性痒疹的一种治疗选择;尽管必须意识到效果可能不是永久性的且存在副作用。目标必须是在有限时间内使用该药物,使患者进入缓解状态,从而抑制恶性循环的瘙痒-搔抓周期。